Belvedere Trading’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Belvedere Trading’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,800	Closed	-$166K	–	979
2024 Q1	$166K	Buy	7,800 +4,900	+169%	+$58.6K	﹤0.01%	364
2023 Q4	$27.9K	Buy	+2,900	New	+$14.1K	﹤0.01%	621

Belvedere Trading's FUSN Position: Q2 2024 in Review

Belvedere Trading sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 33,000 shares — an estimated $704K sold.

Belvedere Trading first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $704K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Belvedere Trading reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Belvedere Trading sold 33,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $704K.
Belvedere Trading first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Belvedere Trading's Fusion Pharmaceuticals Inc. Common Shares position peaked at $704K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Belvedere Trading's 13F filing for Q2 2024, filed 9 Aug 2024.